Astec LifeSciences Limited announced consolidated cash flow results for the year ended March 31, 2016. For the year, the company reported net cash flow from operating activities of INR 54,053,054 compared with INR 74,810,145 for the same period a year ago. Purchase of fixed assets/capital expenditure was INR 259,250,883 compared with INR 201,076,193 for the same period a year ago.